Tristel PLC (TSTL)

Industry Medical Instruments & Supplies

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

385.00p

Buy

399.00p

arrow-up2.00p (+0.51%)

Prices updated at 12 Jun 2026, 17:15 BST

Prices minimum 15 mins delay

Prices in GBX

Tristel PLC’s business is the sale to hospitals of its proprietary chlorine dioxide chemistry used for the decontamination of medical devices under the Tristel brand and for the sporicidal disinfection of environmental surfaces under the Cache brand. ...

FTSE All-Share

1.61%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Instruments & Supplies

Chairman

-

CEO

Mr. Matthew Giovanni Sassone

Most recent earnings

30 Jun 2025

Fiscal year end

30 Jun 2025

Employees

270

Head office

Fordham Road

Snailwell

United Kingdom

CB8 7NY

+44 1638721500

mail@tristel.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Tom Arthur John Jenkins Non-Executive Director, Senior Independent Non-Executive Director	-
Ms. Isabel Josephine Sutherland Napper Non-Executive Director	-
Ms. Caroline Jane Stephens Non-Executive Director	-
Mr. Matthew Giovanni Sassone Executive Director, Chief Executive Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Liontrust Investment Partners LLP	2,681,883
Unicorn Asset Management Ltd	2,470,329
Liontrust UK Smaller Companies Fund	2,339,620
Unicorn AIM VCT Series 3 ORD	1,635,329
Chelverton Asset Management Ltd	877,550

Director dealings

Date chevron-l-regular chevron-r-regular	Action
20 Mar 2026	Purchase
03 Mar 2026	Purchase
03 Mar 2026	Purchase
11 Dec 2025	Purchase

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.